Naloxone Hydrochloride Aurum Pharmaceuticals

Naloxone Hydrochloride, the active ingredient in Naloxone Hydrochloride Aurum Pharmaceuticals, is an opioid antagonist presented as an unspecified strength/solution for intramuscular, intravenous, subcutaneous use. It reverses opioid‑induced respiratory depression in patients experiencing opioid overdose.

GNH USA supplies Naloxone Hydrochloride Aurum Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, offering reliable global distribution and adhering to stringent quality standards.

Naloxone Hydrochloride is used in the management of opioid‑related emergencies, acting to rapidly reverse opioid effects.

- Opioid overdose: rapidly restores normal breathing and consciousness in individuals with life‑threatening respiratory depression. - Opioid toxicity: counteracts severe sedation and pinpoint pupils caused by excess opioids. - Opioid‑induced respiratory depression: improves oxygenation and ventilation in patients receiving high‑dose opioid analgesia. - Opioid‑related cardiac depression: helps normalize heart rate and blood pressure when opioid toxicity compromises cardiovascular function.

Naloxone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Vomiting - Sweating

Serious or Rare Side Effects: - Seizures - Cardiac arrhythmias - Pulmonary edema

When using Naloxone Hydrochloride, several precautions should be observed to ensure safety and effectiveness.

- Assess airway: verify that the patient can maintain a patent airway before administration. - Monitor vital signs: continuously observe respiratory rate, oxygen saturation, and blood pressure after dosing. - Avoid in known hypersensitivity: do not administer to patients with documented allergy to naloxone or its excipients. - Consider cardiac history: patients with underlying heart disease may experience arrhythmias after rapid reversal. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxone may interact with other medications, influencing its efficacy or safety.

Major Interactions (Avoid): - Mixed agonist‑antagonist opioids (e.g., pentazocine, buprenorphine): may precipitate acute withdrawal and reduce analgesia. - High‑dose opioid therapy: may require repeated naloxone dosing, potentially leading to loss of analgesia.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia that signals opioid reversal. - Antihypertensive agents: additive hypotensive effect may occur after naloxone administration. - Tricyclic antidepressants: increased risk of seizures when combined with naloxone.